Molecular characterization of susceptible and naturally resistant strains of Trypanosoma cruzi to benznidazole and nifurtimox

Molecular and Biochemical Parasitology

Volumn 93, Issue 2, 1998, Pages 203-214

  Murta, Silvane M F ^a,b   Gazzinelli, Ricardo T ^a,b   Brener, Zigman ^a   Romanha, Alvaro J ^a  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

Chemotherapy; Drug resistance; Randomly amplified polymorphic DNA; Trypanosoma cruzi; Zymodeme

Indexed keywords

BENZNIDAZOLE; GLYCOPROTEIN P; HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE; ISOENZYME; NIFURTIMOX; RIBOSOME DNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHAGAS DISEASE; CONTROLLED STUDY; DRUG SENSITIVITY; GENETIC VARIABILITY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RANDOM AMPLIFIED POLYMORPHIC DNA; STRAIN DIFFERENCE; TRYPANOSOMA CRUZI;

ANIMALS; BRAZIL; CHAGAS DISEASE; DNA, PROTOZOAN; DNA, RIBOSOMAL; DRUG RESISTANCE; EXONS; GENES, PROTOZOAN; GLUCOSE-6-PHOSPHATE ISOMERASE; HUMANS; HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE; ISOENZYMES; NIFURTIMOX; NITROIMIDAZOLES; P-GLYCOPROTEIN; POLYMORPHISM, GENETIC; RANDOM AMPLIFIED POLYMORPHIC DNA TECHNIQUE; TRYPANOCIDAL AGENTS; TRYPANOSOMA CRUZI; VARIATION (GENETICS);

EID: 17344379918     PISSN: 01666851     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-6851(98)00037-1     Document Type: Article

References (39)

1. [1] WHO. Control of Chagas disease. Report a WHO Expert Committee. Geneva. WHO Techn Rep Sers 1991;95:811.
2. [2] De Castro S. The challenge of Chagas' disease chemotherapy: an update of drugs assayed against Trypanosoma cruzi. Acta Trop 1993;53:83-98.
3. [3] Haberkorn A, Gonnert R. Animal experimental investigations in the activity of nifurtimox against Trypanosoma cruzi. Arzneim-Forsch 1972;22:1570-80.
4. [4] Andrade S, Magalhaes JB, Pontes AL. Evaluation of chemotherapy with benznidazole and nifurtimox in mice infected with Trypanosoma cruzi strains of different types. Bull WHO 1985;63:721-6.
5. [5] Filardi LS, Brener Z. Susceptibility and natural resistance of Trypanosoma cruzi strains to drugs used clinically in Chagas' disease. Trans R Trop Med Hyg 1987;81:755-9.
6. [6] Rassi A, Luquetti AO. Therapy of Chagas disease. In: Wendel S, Brener Z, Camargo ME, Rassi A, editors. Chagas disease (American Trypanosomiasis): its impact on transfusion and clinical medicine: ISBT Brazil '92, 1992:237-47.
7. [7] Miles MA, Souza AA, Povoa MM, Shaw JJ, Lainson R, Toyé PJ. Isozymic heterogeneity of Trypanosoma cruzi in the first authocthonous patients with Chagas' disease in Amazonian Brazil. Nature 1978;272:819-21.
8. [8] Morel CM, Chiari E, Camargo EP, Mattei DM, Romanha AJ, Simpson L. Strains and clones of Trypanosoma cruzi can be characterized by pattern of restriction endonuclease products of kinetoplast DNA minicircles. Proc Natl Acad Sci USA 1980;77:6810-4.
9. [9] Macedo AM, Martins MS, Chiari E, Pena SDJ. DNA fingerprinting of Trypanosoma cruzi: a new tool for characterization of strains and clones. Mol Biochem Parasitol 1992;55:147-54.
10. [10] Dirie MF, Murphy NB, Gardiner PR. DNA fingerprinting of Trypanosoma vivax isolates rapidly identifies intraspecific relationships. J Euk Microbiol 1993;40:132-4.
11. [11] Steindel M, Dias Neto E, Menezes CLP, Romanha AJ, Simpson AJG. Random amplified polymorphic DNA analysis of Trypanosoma cruzi strains. Mol Biochem Parasitol 1993;60:71-80.
12. [12] Tibayrenc M, Neubauer K, Barnabé C, Guerrini F, Skarecky D, Ayala F. Genetic characterization of six parasitic protozoa: Parity between random-primer DNA typing and multilocus enzyme electrophoresis. Proc Natl Acad Sci USA 1993;90:1335-9.
13. [13] Souto R, Fernandes O, Macedo A, Campbell D, Zingales B. DNA markers define two major phylogenetic lineages of Trypanosoma cruzi. Mol Biochem Parasitol 1996;83:141-52.
14. [14] Nunes LR, De Carvalho MRC, Buck GA. Trypanosoma cruzi strains partition into two groups based on the structure and function of the spliced leader RNA and rRNA gene promoters. Mol Biochem Parasitol 1997;86:211-24.
15. [15] Fernandes CD, Murta SMF, Cerávolo IP, et al. Characterization of Trypanosoma cruzi strains isolated from chronic chagasic patients, triatomines and opossums naturally infected from the State of Rio Grande do Sul, Brazil. Mem Inst Oswaldo Cruz 1997;92:343-51.
16. [16] Fernandes AJ, Chiari E, Ribeiro-Rodrigues R, Dias JCP, Romanha AJ. The importance of the opossum (Didelphis albiventris) as a reservoir for Trypanosoma cruzi in Bambuí Minas Gerais State. Mem Inst Oswaldo Cruz 1991;86:81-5.
17. [17] Camargo EP. Growth and differentiation in Trypanosoma cruzi. I. Origin of metacyclic trypanosome in liquid media. Rev Inst Med Trop Sao Paulo 1964;6:93-100.
18. [18] Carneiro M, Chiari E, Gonçalves AM, da Silva Pereira AA, Morel CM, Romanha AJ. Changes in the isoenzyme and kinetoplast DNA patterns of Trypanosoma cruzi strains induced by maintenance in mice. Acta Trop 1990;47:35-45.
19. [19] Filardi LS, Brener Z. A rapid method for testing in vivo the susceptibility of different strains of Trypanosoma cruzi to active chemotherapeutic agents. Mem Inst Oswaldo Cruz 1984;79:221-5.
20. [20] Brener Z. Therapeutic activity and criterion of cure on mice experimentally infected with Trypanosoma cruzi. Rev Inst Med Trop Sao Paulo 1962;4:389-96.
21. [21] Santos FR, Pena SDJ, Epplen JT. Genetic and population study of an Y-linked tetranucleotide repeat DNA polymorphism. Hum Genet 1993;90:655-6.
22. [22] Dice LR. Measures of the amount of ecological association between species. Ecology 1945;26:297-302.
23. [23] Sneath PHA, Sokal RR. Numerical taxonomy. Nature 1962;193:853-60.
24. [24] Dallagiovanna B, Castanys S, Gamarro F. Trypanosoma cruzi: Sequence of the ATP-binding site of a P-glycoprotein gene. Exp Parasitol 1994;79:63-7.
25. [25] Allen T, Ullman B. Molecular characterization and overexpression of the hypoxanthine-guanine phosphoribosyl-transferase gene from Trypanosoma cruzi. Mol Biochem Parasitol 1994;65:233-45.
26. [26] Luquetti AO, Miles MA, Rassi A, et al. Trypanosoma cruzi: zymodemes associated with acute and chronic Chagas' disease in Central Brazil. Trans R Trop Med Hyg 1986;80:462-70.
27. [27] Andrade S, Magalhaes JB. Biodemes and zymodemes of Trypanosoma cruzi strains: correlations with clinical data and experimental pathology. Rev Soc Bras Med Trop 1997;30:27-35.
28. [28] Cerisola J, Alvarez M, Rissio A. Imunodiagnóstico da Doença de chagas. Evoluçao sorológica de pacientes com Doença de chagas. Rev Inst Med Trop Sao Paulo 1970;26:403-11.
29. [29] Schenone H, Concha L, Aranda R, Rojas A, Knierim F, Rojo M. Tratamiento de la infecction chagasica cronica con Lampit. Bol Chil Parasitol 1972;27:11-4.
30. [30] Cerisola JA, Neves da Silva N, Prata A, Schenone H, Rohwedder R. Evaluation mediante xenodiagnostico de Ia efectividad del nifurtimox en la infection chagasica cronica. Bol Chil Parasitol 1977;32:51-62.
31. [31] Ferreira HO. Ensaio terapêutico-clínico com o benznidazol na doença de Chagas. Rev Inst Med Trop Sao Paulo 1976;18:357-64.
32. [32] Montamat E, D'Oro G, Perret B, Rivas C. Characterization of Trypanosoma cruzi from Argentina by electrophoretic zymograms. Acta Trop 1992;50:125-33.
33. [33] Montamat E, D'Oro G, Gallerano R, Sosa R, Blanco A. Characterization of Trypanosoma cruzi populations by zymodemes: correlation with clinical picture. Am J Trop Med Hyg 1996;55:625-8.
34. [34] Apt W, Aguilera X, Arribada A, Gomez L, Miles M, Widmer G. Epidemiology of Chagas disease in Northern Chile: isozyme profiles of Trypanosoma cruzi from domestic and sylvatic transmission cycles and their association with cardiopathy. Am J Trop Med Hyg 1987;37:302-7.
35. [35] Greif G, Stephan B, Haberkorn A. Intraspecific polymorphisms of Eimeira species due to resistance against anticoccidial drugs. Parasitol Res 1996;82:706-14.
36. [36] Lescuyer P, Picot S, Bracchi V, et al. Detection of RAPD markers correlated with chloroquine resistance in Plasmodium falciparum. Genome Res 1997;7:747-53.
37. [37] Ullman B. Multidrug resistance and P-glycoprotein in parasitic Protozoa. J Bioenerg Biomemb 1995;27:77-84.
38. [38] Foote SJ, Kyle DE, Martin RK, et al. Several alleles of the multidrug-resistance gene are closely linked to chloroquine resistance in Plasmodium falciparum. Nature 1990;345:255-8.
39. [39] Dallagiovanna B, Gamarro F, Castanys S. Molecular characterization of a P-glycoprotein-related tcpgp2 gene in Trypanosoma cruzi. Mol Biochem Parasitol 1996;75:145-57.